IRSp53 Antibodies

Santa Cruz Biotechnology features a diverse variety of IRSp53 monoclonal antibodies for research focused on understanding IRSp53 protein functions. IRSp53 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IRSp53, or insulin receptor substrate p53, is a critical protein involved in actin cytoskeleton remodeling and cell signaling pathways. IRSp53 plays a significant role in neuronal development and synaptic function, making it essential for understanding neurobiology and related disorders. Research has shown that IRSp53 influences cellular morphology through its interaction with membrane dynamics and cytoskeletal components. IRSp53 has been implicated in cancer progression, highlighting its importance in tumor biology and potential therapeutic targets. Scientists studying cell migration and membrane dynamics frequently utilize IRSp53 monoclonal antibodies to advance their research. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful contributions to scientific understanding of cellular processes and disease mechanisms.